AstraZeneca Pharma India Ltd to Hold Board Meeting for Q1 Financial Results
AstraZeneca Pharma India Limited has scheduled a meeting of its Board of Directors to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30, 2026.The Board meeting is set to take place on Monday, August 10, 2026.
In addition to the financial review, the company confirmed the status of its trading restrictions. The 'Trading Window' remains closed for all Designated Persons from June 16, 2026, to August 12, 2026, as per AstraZeneca Pharma India Limited Code of Conduct for Prevention of Insider Trading.
ASTRAZEN Stock Price Movement
As of 10:38 AM, shares of AstraZeneca Pharma India Limited are slipping by 0.86% in live trading, currently trading at ₹8228.5 after shedding ₹71.50 from their previous close. The stock traded 1,580 shares during the session, remaining below its intraday high of ₹8293.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.